NASDAQ$BKYI
Bio-key International Inc · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
BIO-key's Q1 2020 financial performance improved substantially compared to the same period in 2019, driven by gross profit improvement and decreased operating expenses.
BIO-key reported a decrease in Q1 2020 revenue, but a significant improvement in gross margin and a reduction in operating loss compared to Q1 2019. The company's focus on large African contracts positions it for substantial revenue growth in 2020.
- Q1 2020 revenues declined to $530,000 from $552,000 in Q1 2019.
- Gross margin improved to 67% in Q1 2020 versus a negative gross margin in Q1 2019.
- Q1 2020 operating expenses declined to $1.7 million from $1.8 million.
- Operating loss was reduced to $1.3M in Q1 2020 versus $1.8M in Q1 2019.
Headline financials
Revenue & EPS history
Bio-key · Revenue · Quarterly
$535K
Forward guidance
BIO-key has a strong outlook for 2020 and expects to commence work on its large African contracts in the coming months, leading to substantial revenue growth.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2019
-3.5%
Avg return
Earnings day
-5.3%
Avg return
5 days after
-8.9%
Avg return
30 days after
25%
16 / 63 earnings
Positive
+15.9%
Q1 2017
Best reaction
-25.9%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.7% | — | — | |
| Q3 2025 | -2.2% | -4.1% | -27.8% | |
| Q1 2025 | -6.0% | -2.5% | -2.5% | |
| Q2 2025 | -1.3% | -3.7% | -4.9% | |
| Q4 2024 | -23.6% | +2.4% | -6.0% | |
| Q3 2024 | -8.7% | -16.5% | -5.8% | |
| Q2 2024 | -12.0% | -12.0% | +8.5% | |
| Q1 2024 | -11.8% | -10.0% | +5.9% | |
| Q4 2025 | -4.1% | -9.5% | -15.0% | |
| Q4 2023 | -4.8% | -13.8% | -19.0% | |
| Q3 2023 | -10.6% | -15.8% | -10.5% | |
| Q2 2023 | -10.0% | -10.0% | -27.1% | |
| Q1 2023 | +5.3% | +21.5% | +13.8% | |
| Q4 2022 | -3.0% | +8.2% | -9.6% | |
| Q3 2022 | -17.4% | -27.1% | -45.1% | |
| Q2 2022 | -17.0% | -22.6% | -27.6% | |
| Q1 2022 | -2.0% | -6.0% | -17.9% | |
| Q4 2021 | -3.2% | -6.0% | -14.0% | |
| Q3 2021 | -8.2% | -10.8% | -27.5% | |
| Q2 2021 | -7.4% | -5.5% | +3.5% | |
| Q1 2021 | +6.1% | +8.4% | +32.3% | |
| Q4 2020 | +2.9% | -0.9% | -2.6% | |
| Q3 2020 | -8.7% | -4.4% | -3.3% | |
| Q2 2020 | +1.1% | -1.4% | -36.5% | |
| Q4 2019 | -24.2% | -20.7% | -9.8% | |
| Q3 2019 | -9.2% | -12.1% | +0.0% | |
| Q2 2019 | +1.8% | -6.8% | -29.5% | |
| Q1 2019 | -6.2% | -16.9% | -13.1% | |
| Q4 2018 | -6.8% | -4.8% | -9.5% | |
| Q3 2018 | +11.1% | +9.3% | +13.9% | |
| Q2 2018 | -2.2% | -2.2% | -10.4% | |
| Q1 2018 | -11.0% | -1.3% | -0.9% | |
| Q4 2017 | -6.5% | +2.0% | +7.6% | |
| Q3 2017 | -10.8% | -6.1% | -29.1% | |
| Q2 2017 | -3.1% | -4.3% | -10.6% | |
| Q1 2017 | +15.9% | +22.0% | +17.5% | |
| Q4 2016 | -7.8% | -5.1% | -14.1% | |
| Q3 2016 | -25.9% | -7.4% | -18.5% | |
| Q2 2016 | +0.0% | -4.2% | +8.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | +0.0% | — | — | |
| Q2 2015 | +5.6% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | +0.0% | — | — | |
| Q1 2014 | -3.7% | — | — | |
| Q4 2013 | +7.7% | — | — | |
| Q3 2013 | -10.5% | — | — | |
| Q2 2013 | +3.0% | — | — | |
| Q1 2013 | +9.1% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | +14.3% | — | — | |
| Q1 2012 | +14.3% | — | — | |
| Q4 2011 | -9.1% | — | — | |
| Q3 2010 | -15.4% | — | — | |
| Q3 2011 | -15.4% | — | — | |
| Q2 2010 | +9.1% | — | — | |
| Q2 2011 | +9.1% | — | — | |
| Q1 2011 | -6.7% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro